The BioIT Alliance will be holding its first annual BioIT Alliance Meeting and Conference.
Microsoft founded the BioIT Alliance with the goal of fostering collaborations between companies in the translational medicine space, with those collaborations used to jump-start standards development for interoperability.
The Alliance unites the pharmaceutical, biotech, hardware, and software industries to explore new ways to share complex biomedical data and collaborate among multi-disciplinary teams to speed the pace of discovery in the life sciences.
Now Microsoft is going a step further by having the BioIT Alliance be a separate entity, while keeping the same goal: enabling interoperability between applications, equipment, and other resources necessary to enable translational medicine.
The inaugural BioIT Alliance Conference will be held on October 8 & 9, 2009 at the Microsoft New England Research and Development Campus in Cambridge, MA. The conference is free and open to Life-Science Industry practitioners.
The meeting features presentations from key thought leaders in the pharmaceutical, biotech, hardware, and software industries.
The Conference agenda follows:
Thursday, October 8
12:30 – Conference Kick off
1:00pm to 5:00pm – Presentations by:
- Les Jordan, Director BioIT Alliance – Directions on the BioIT Alliance
- Rebecca Kush, President, CDISC – CDISC in the World of Standards for Medical Research
- Daniel Matlis, President, Axendia – The Future of the FDA, Operating in an Electronic World
- Michael Stapleton, VP of Corporate Development, CambridgeSoft - Delivering Search Innovation to the Research Industry
- Steve Heller, NIST - IUPAC InChi and the BioIT Alliance
5:30 – Reception at the upper floors of the Microsoft New England Research and Development Campus
Friday, October 9
9:00am to noon – Presentations by:
- Sasha Paegle, Sr. Research Product Manager, Microsoft - Microsoft Amalga Life Sciences & opportunities for interoperability
- Frank Brown, Chief Science Officer, Accelrys - Standards for Scientific Web services to integrate the commercial domain and build “ELN 2.0”
- Dave Champagne, VP and GM, Thermo Fisher – Directions on Translational Medicine
- Chris Waller, Director, Pre-Competitive Collaborations, Pfizer – The Pistoia Alliance and the BioIT Alliance
Register for the conference at http://msevents.microsoft.com/CUI/EventDetail.aspx?EventID=1032424558About the BioIT Alliance:
The Alliance is a group of organizations working together to realize the potential of personalized medicine. The Alliance unites the pharmaceutical, biotech, hardware, and software industries to explore new ways to share complex biomedical data and collaborate among multi-disciplinary teams to speed the pace of discovery in the life sciences.
Life Science companies have unique technical challenges in data integration, collaboration, and knowledge management that cannot be solved by any organization alone. The BioIT Alliance brings together science and technology leaders to consider innovative ways to address these challenges and use technology to reduce costs, streamline research, and market their products more effectively.